Skip to main content

Closed

RNA: Atrium Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.56×avg

Market Cap

194.15MUSD

P/E Ratio

-4.3TTM

Div Yield

-ann

Atrium Therapeutics, Inc.

RNANASDAQ Global Select·USD·Closed

Atrium Therapeutics, Inc.

RNANASDAQ·USD·Closed

$11.35

−0.96%

$11.35

−$0.11 (0.96%)

52W Range

4thpctl

Volume

0.56×avg

Mkt Cap

194.15MUSD

P/E

-4.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings